ClinicalTrials.gg
RecruitingNCT07667010ANGLEDUpdated Oct 28, 2026

Hyperangulated vs. Macintosh Style Blades for Intubation in Obstetric Patients

An interventional study of Macintosh Style Blade and Hyperangulated blade in Obstetric, Cesarean Birth and Airway Anesthesia, sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Recruiting at 1 site in Canada. Open to female participants. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Oct 28, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Sex
Female
01

Study summary

Cesarean section under general anesthesia requires intubation (insertion of a tube through the mouth into the breathing pipe to support breathing during the surgery). A device called a video laryngoscope is used, which has a smooth, curved, or less curved component called 'a blade' that helps the doctor gently see the voice box and guide the breathing tube safely into place during anesthesia; it is not a sharp tool blade.

There are two types of video laryngoscopes blades: a Macintosh- style blade with a gentle curve, approximately 90 degrees) and a hyperangulated blade (with a more pronounced curve).

Although video laryngoscopes are safe and both types have been used for around 20 years, it is not known whether one type works better that the other in patients undergoing cesarean delivery under general anesthesia. Because general anesthesia is used in only a small proportion (about 5%) of all cesarean deliveries, research in this area is limited.

The main purpose of the study is to assess if a study comparing these two types of blades in the obstetric population is feasible. This is also known as a feasibility study, which aims to test the study plan and determine whether enough participants will join a larger study and accept the study procedures. The results will be used as a guide for a larger study.

Read the detailed description

Study design and setting.

This will be a single-site, prospective feasibility study conducted within the Department of Anesthesia and Pain management, Mount Sinai Hospital, Toronto, a high-volume tertiary obstetric centre with established expertise in obstetric anesthesia and airway research.

Intervention and Cluster Assignment

Because individual randomization immediately before induction is often impractical in obstetric emergencies, blade assignment will occur by randomized time-based clusters. Randomization will occur in 4 clusters of 4 months each, separated by one-month washout periods. Four consecutive four-month periods will be randomly assigned to use either a hyperangulated or Macintosh-style blade as the default for the first intubation attempt. Clinicians may deviate from the assigned blade for patient safety. The time-block design minimizes contamination associated with rapid decision-making in obstetric emergencies and aligns with real-world workflow on labour and delivery units.

Randomization

Time-block cluster allocation will be generated by a study statistician who is not involved in clinical care, participant enrollment, or study implementation. The allocation schedule will be finalized prior to study initiation and maintained without modification.

Data Collection

A trained research assistant will extract patient demographic and perioperative data from the electronic medical record and confirm key airway variables with the attending anesthesiologist within 72 hours of Cesarean delivery (CD). Patients will be contacted by telephone on postoperative day 3 to assess airway-related morbidity, including minor oral or dental injuries (lacerations of the lips, teeth, tongue, or oral mucosa) and postoperative sore throat.

Outcomes

The primary feasibility outcomes are patient enrollment, intervention adherence, and data completeness .

Each feasibility outcome will be assessed against its predefined threshold to determine whether to proceed to a full-scale randomized controlled trial (RCT), proceed with protocol modifications, or discontinue the study if feasibility cannot be achieved despite modifications. Recruitment strategies will be adapted if enrollment falls below two patients per week for several consecutive weeks. Feasibility will be interpreted using a green/yellow/red framework. Outcomes meeting green thresholds will be considered feasible (>80%); outcomes meeting yellow thresholds will prompt protocol modification (60-79%); and outcomes meeting red thresholds will be considered not feasible (\<60%). Secondary exploratory outcomes include first-attempt intubation success, number of intubation attempts, need for rescue airway techniques, and airway-related complications.

Potential risks associated:

This study poses minimal risk to participants, as it compares two standard-of-care video-laryngoscope blades used by experienced clinicians, with no restriction on clinical judgment or rescue airway management. Both hyperangulated and Macintosh-style video-laryngoscope blades are widely used, approved devices and are part of standard clinical practice at Mount Sinai Hospital. No experimental devices or techniques are being introduced. The choice of blade does not expose participants to risks beyond those already inherent to general anesthesia (GA) and tracheal intubation for cesarean delivery.

Sample Size

A pragmatic sample of 100 participants will be enrolled over 19 months. This sample is sufficient to estimate feasibility parameters with acceptable precision but is not powered to detect clinical superiority.

Statistical Analysis

Feasibility outcomes will be summarized descriptively using proportions and 95% confidence intervals and evaluated using the pre-specified green/yellow/red framework to guide progression to a multicentre RCT. Descriptive statistics will be used to summarize patient characteristics and secondary outcomes. Categorical variables will be summarized as frequencies and percentages; continuous variables as means with standard deviation.

Significance/Importance

By establishing feasibility for a definitive multicentre RCT, this study represents a critical step toward optimizing airway management during CD under general anesthesia. Ultimately, this work has the potential to improve first-attempt intubation success, reduce airway-related complications, and enhance maternal and fetal safety nationwide.

02

Conditions studied

  • Obstetric
  • Cesarean Birth
  • Airway Anesthesia
  • Intubation
  • General Anesthesia; Tracheal Intubation
  • Video Laryngoscopy
  • Obstetric Anesthesia
  • Obstetric Anesthesia Problems
  • General Anesthesia

Keywords

  • obstetric
  • obstetric anesthesia
  • intubation
  • airway safety in OB patients
  • video laryngoscopy
  • cesarean delivery
  • general anesthesia in cesarean delivery
  • macintosh blade
  • hyperangulated blade
  • intubation in OB patients
  • general anesthesia
03

In context

Lead sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital is the lead sponsor of 138 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

1. Pregnant patients undergoing emergency or urgent cesarean delivery under general anesthesia requiring tracheal intubation.

Exclusion criteria

Exclusion Criteria:

  1. No tracheal intubation performed and (ii) patient refusal of consent.
  2. Patients not receiving general anesthesia.
  3. Patients that previously participated in the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Macintosh style blade

    Study patients in this arm will be intubated using a Macintosh style blade

    Device: Macintosh Style Blade

  • Active comparator
    Hyperangulated blade

    Study patients in this arm will be intubated using a Hyperangulated style blade

    Device: Hyperangulated blade

Interventions

  • DeviceMacintosh Style Blade

    Macintosh- style blade with a gentle curve, approximately 90 degrees

  • DeviceHyperangulated blade

    hyperangulated blade (with a more pronounced curve

06

What researchers measure

Primary outcomes

  1. Patient Enrollment

    Percentage of eligible cesarean deliveries under general anesthesia in which patients are recruited and consented

    Time frame: 3 days

  2. Intervention Adherence

    Percentage of cases in which the assigned time-block blade was used for the first intubation attempt, with documentation of crossovers and reasons

    Time frame: 3 days

  3. Data Completeness

    Percentage of patients with complete data on key airway and perioperative outcomes including postoperatively 3-day follow-up data.

    Time frame: 3 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — This is a feasibility study

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for Jan 2028, 19 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 15, 2026
First posted
Jun 24, 2026
StartActual
Jun 22, 2026
Primary completionEst.
Jan 31, 2028
CompletionEst.
Jun 30, 2028
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 28, 2026
Sites
Mount Sinai Hospital is now Recruiting
Oct 28, 2026
Start date
Jun 15, 2026→Jun 22, 2026 (actual)
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    Not yet recruiting→Recruiting
    Mount Sinai Hospital is now Recruiting
    Start date Jun 15, 2026→Jun 22, 2026 (now actual)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07667010
Responsible party
Sponsor
First posted
Jun 24, 2026
Start date
Jun 22, 2026
Primary completion
Jan 31, 2028 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Oct 28, 2026

Study contacts

Fabricio B Zasso, MD
Contact
fabricio.zasso@uhn.ca
(416) 586-4800 ext. 5270

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion